Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shock therapy for bedwetting? TENS device shows promise in kids

NCT ID NCT04313192

Symptom relief Sponsor: Albany Medical College Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested three different frequencies of a TENS device (a mild electrical stimulation machine) to see which works best for treating bedwetting in children. 125 children who had not improved with behavioral changes were randomly assigned to use a TENS unit at 2, 10, or 150 Hz for 15 minutes each night for 30 days. The goal was to compare how much bedwetting decreased and how the children's quality of life improved.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
transcutaneous electrical nerve stimulation (TENS) device
What this could lead to
If successful, this could identify the most effective TENS frequency to reduce bedwetting in children, offering a drug-free option.
What could go wrong
This is a small, completed trial with no phase designation, so results may not be widely applicable. The device may not work for all children, and some may find it uncomfortable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

125 people

The number who actually took part.

Started

Jan 2020

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

5 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Presenting with nocturnal enuresis (more than 1x a week) 2. Failed Behavioral modification treatment (limiting evening drinking, double voiding prior to bedtime, bowel habits, social anxiety factors) 3. Ability to provide informed consent and assent and complete study requirements Exclusion Criteria: 1. Patients who have previously tried pharmacologic treatment for nocturnal enuresis, neuromodulation or other alternative therapy for urologic disorders within the past 30 days 2. Daytime incontinence symptoms 3. Known "high volume" voiders (determined from history) 4. Bedwetting episodes on the average of less than two times per week, 5. Medications predisposing to incontinence (eg, Lithium for bipolar disorder) 6. Other known voiding or neurologic disorders (eg, overactive bladder, myelomeningocele, interstitial cystitis, etc) 7. Secondary etiologies for nocturnal enuresis (eg, cystitis, obstructive sleep apnea, urinary fistulae, heart disease) 8. Any contraindications to usage of a TENS unit (pacemaker or other implantable device, lymphedema, pregnancy, malignancy,bleeding or clotting disorders, unhealthy tissue, seizure disorders, impaired cognition) 9. Any history of heart disease or complications

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bed wetting are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

nocturnal enuresis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bed wetting Nocturnal enuresis

Contacts and locations

Locations

  • Albany Medical College

    Albany, New York, 12208, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.